In a study investigating CCL2 gene expression using tumor specimens from 37 ovarian cancer patients, CCL2 mRNA expression was correlated with objective complete response, chemosensitivity, and progression-free survival [88]. The gene discussed is CCL2; the disease is ovarian cancer.